Insider Transactions in Q3 2025 at Dyne Therapeutics, Inc. (DYN)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 05
2025
|
John Cox CEO & President |
SELL
Open market or private sale
|
Direct |
2,640
-1.31%
|
$34,320
$13.41 P/Share
|
|
Sep 05
2025
|
Johanna Friedl Naderer Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
144
-0.15%
|
$1,872
$13.41 P/Share
|
|
Sep 05
2025
|
Douglas Kerr Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
873
-0.98%
|
$11,349
$13.41 P/Share
|
|
Sep 04
2025
|
Johanna Friedl Naderer Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
894
-0.93%
|
$11,622
$13.27 P/Share
|
|
Sep 04
2025
|
Douglas Kerr Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,552
-3.83%
|
$46,176
$13.27 P/Share
|
|
Jul 15
2025
|
John Cox CEO & President |
SELL
Bona fide gift
|
Direct |
40,000
-4.41%
|
-
|
|
Jul 14
2025
|
John Cox CEO & President |
BUY
Open market or private purchase
|
Direct |
100,000
+29.22%
|
$900,000
$9.11 P/Share
|